Industry Developments

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10

BMI View: A month after Brazil's largest consumer products conglomerate announced plans to offload non-core assets and concentrate on its pharmaceutical and personal hygiene divisions,... 2011-11-08

BMI View: While we do not foresee an improvement in Cuba's overall business environment any time soon, we maintain that the country's biopharmaceutical sector remains largely under... 2011-11-07

BMI View: Pfizer's decision to shed its nutrition and animal health businesses will be welcomed by investors, who are displaying preferences for pure-play pharmaceutical companies.... 2011-11-04

BMI View: While we believe Chile's pharmaceutical industry is short-sighted and self-serving in its opposition to new government bioequivalence certification standards, we concede that... 2011-11-04

BMI View: Ecuador's decision to invest in its ailing public healthcare infrastructure has resulted in higher than expected spending announcements. However, the government's decision... 2011-11-03

BMI View: Although Agência Nacional de Saúde Suplementar (ANS) has reaffirmed its aim to provide universal healthcare, BMI believes persistent shortcomings across the country's publicly... 2011-11-01

BMI View: Although healthcare funding announcements by the Peruvian government promise to introduce much needed medicines and healthcare equipment, we note that its focus on large-scale... 2011-10-31

BMI View: Bucking a global push towards over-the-counter (OTC) medicines, governments across Latin America have responded to a series of scandals by clamping down on pharmacy sales.... 2011-10-28

BMI View: While news that Canadian authorities have tightened public drug plans will come as no surprise, reimbursement trends favouring cost-effective studies over clinical success... 2011-10-26